Department of Obstetrics and Gynecology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.
Int J Gynaecol Obstet. 2010 Dec;111(3):249-52. doi: 10.1016/j.ijgo.2010.06.022.
To compare visual inspection with acetic acid (VIA) with conventional cervical cytology as a follow-up cervical cancer screening method in women who had been treated previously with cryotherapy.
Salvadoran women screened with VIA and treated with cryotherapy within 3 years were eligible to participate. Study participants were rescreened with VIA, Pap smear, colposcopy, 4-quandrant biopsy, and endocervical curettage.
Of 147 women enrolled in the study, post-cryotherapy VIA was positive in 39 women (26.5%; 95% CI, 19.6%-34.4%). Of these 39, 1 woman had CIN 1 or higher on biopsy. Post-cryotherapy Pap smear was positive (ASCUS or higher) in 6 women (4.1%; 95% CI, 1.5%-8.7%). Of these 6, 2 women had CIN 1 or higher on biopsy. Post-cryotherapy specificity was significantly higher for Pap compared with VIA (95.8% [138/144]; 95% CI, 91.2%-98.5% vs 73.6% [106/144]; 95% CI, 65.6%-80.6%; P<0.001).
As the single-visit approach for cervical cancer screening gains popularity, more women will have been treated with cryotherapy. Appropriate follow-up screening is therefore vital. Cytology may be a more suitable screening method than VIA in low-resource settings for women treated previously with cryotherapy.
比较醋酸视觉检查(VIA)与传统巴氏细胞学检查作为宫颈冷冻治疗后妇女的宫颈癌随访筛查方法。
VIA 筛查并在 3 年内接受冷冻治疗的萨尔瓦多妇女有资格参加本研究。研究参与者接受 VIA、巴氏涂片、阴道镜检查、四点活检和宫颈搔刮术复查。
在 147 名入组的妇女中,39 名(26.5%;95%CI,19.6%-34.4%)冷冻治疗后 VIA 阳性。这 39 名妇女中,1 名妇女活检显示 CIN1 或更高级别病变。冷冻治疗后巴氏涂片阳性(ASCUS 或更高级别)的有 6 名妇女(4.1%;95%CI,1.5%-8.7%)。这 6 名妇女中,2 名妇女活检显示 CIN1 或更高级别病变。与 VIA 相比,冷冻治疗后巴氏涂片的特异性明显更高(95.8%[138/144];95%CI,91.2%-98.5%比 73.6%[106/144];95%CI,65.6%-80.6%;P<0.001)。
随着单次就诊宫颈癌筛查方法的普及,更多的妇女将接受冷冻治疗。因此,适当的随访筛查非常重要。对于接受过冷冻治疗的妇女,细胞学可能是比 VIA 更适合在资源有限的情况下进行筛查的方法。